Drug Shortage Report for ROFACT
| Report ID | 93236 |
| Drug Identification Number | 00393444 |
| Brand name | ROFACT |
| Common or Proper name | ROFACT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | RIFAMPIN |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | n/a |
| ATC code | J04AB |
| ATC description | DRUGS FOR TREATMENT OF TUBERCULOSIS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-01-10 |
| Estimated end date | |
| Actual end date | 2020-03-16 |
| Shortage status | Resolved |
| Updated date | 2020-03-18 |
| Company comments | new lots are in transit |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v34 | 2020-03-18 | French | Compare |
| v33 | 2020-03-18 | English | Compare |
| v32 | 2020-03-12 | French | Compare |
| v31 | 2020-03-12 | English | Compare |
| v30 | 2020-03-12 | English | Compare |
| v29 | 2020-02-28 | French | Compare |
| v28 | 2020-02-28 | English | Compare |
| v27 | 2020-02-03 | French | Compare |
| v26 | 2020-02-03 | English | Compare |
| v25 | 2020-02-03 | French | Compare |
| v24 | 2020-02-03 | English | Compare |
| v23 | 2020-01-16 | French | Compare |
| v22 | 2020-01-16 | English | Compare |
| v21 | 2020-01-15 | French | Compare |
| v20 | 2020-01-15 | English | Compare |
| v19 | 2020-01-10 | English | Compare |
| v18 | 2020-01-09 | French | Compare |
| v17 | 2020-01-09 | English | Compare |
| v16 | 2019-12-17 | English | Compare |
| v15 | 2019-12-11 | French | Compare |